Skip to content

Transcatheter Aortic Valve Implantation Registry of the University Heart Centre Freiburg - Bad Krozingen

Transcatheter Aortic Valve Implantation Registry of the University Heart Centre Freiburg - Bad Krozingen - TAVI FR-BK-Register

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00029242
Enrollment
5000
Registered
2023-03-27
Start date
2023-01-16
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I35.0

Interventions

Group 1: Patients with high-grade aortic valve stenosis who receive a regular TAVR

Sponsors

Universitätsklinikum Freiburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: All adult patients who have received or will receive a transcatheter aortic valve implantation (TAVI) at the University Heart Centre Freiburg - Bad Krozingen or who will receive screening for this purpose will be included. Patients participating in the prospective long-term follow-up require prior written information and consent.

Exclusion criteria

Exclusion criteria: Apart from the patient's refusal to participate, there are no direct exclusion criteria, as this is only a collection of data from an intervention that is being carried out anyway.

Design outcomes

Primary

MeasureTime frame
- Primary hospitalisation or TAVI procedure - Success of the TAVI procedure - Post-interventional function of the aortic valve prosthesis - Frequency of periinterventional complications - Long-term assessment of implantation success - Function of the aortic valve prosthesis during follow-up - Post-interventional complications after TAVI procedure - Mortality after TAVI procedure during follow-up - Health-related quality of life (HRQL) - NYHA score - Canadian Cardiovascular Society (CCS) Angina Grade - EuroQoL 5D (EQ-5D-5L) - Toronto Aortic Stenosis Quality of Life questionnaire (TASQ) >> Endpoints for long-term follow-up are collected after 6 months and after 1, 2, 3, 4 and 5 years

Secondary

MeasureTime frame
o Investigation of factors influencing periprocedural complications, post-interventional function of the aortic valve prosthesis and the success of the TAVI procedure. o Demographic factors o Symptoms of aortic valve stenosis o Pre- and periinterventional parameters: Laboratory, ECG, echocardiography, computed tomography, MRI, coronary angiography. o Procedural characteristics of the TAVI procedure o Investigation of factors influencing the function of the aortic valve prosthesis in the course, post-interventional complications after TAVI procedure, mortality in the course after TAVI procedure, health-related quality of life (HRQL) o Demographic factors o Symptomatology of aortic valve stenosis o Pre- and periinterventional parameters: Laboratory, ECG, echocardiography, computed tomography, MRI, coronary angiography. o Procedural characteristics of the TAVI procedure

Countries

Germany

Contacts

Public ContactConstantin von zur Mühlen

Universitätsklinikum Freiburg

constantin.vonzurmuehlen@universitaets-herzzentrum.de0761/270-34415

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 6, 2026